Glen C. MacDonald
Chief Executive Officer en Leucadia Finance Partners, Inc. .
Fortuna: 51 461 $ al 29/02/2024
Perfil
Presently, Glen C.
MacDonald holds the position of Chief Technology Officer of Sesen Bio, Inc. and President, CEO, CFO & Director at Leucadia Finance Partners, Inc.
In the past he occupied the position of Chief Scientific Officer at Viventia Biotech, Inc., Chief Scientific Officer for Viventia Bio, Inc., Principal at Princess Margaret Hospital Foundation and Principal at The University of North Carolina at Charlotte.
He received a doctorate and a graduate degree from the University of Manitoba and an undergraduate degree from the University of Guelph.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
02/03/2023 | 19 946 ( 0.05% ) | 51 461 $ | 29/02/2024 |
Cargos activos de Glen C. MacDonald
Empresas | Cargo | Inicio |
---|---|---|
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Leucadia Finance Partners, Inc. provides investment services. The company was founded on January 12, 2014 and is headquartered in Vancouver, Canada. | Chief Executive Officer | - |
Antiguos cargos conocidos de Glen C. MacDonald.
Empresas | Cargo | Fin |
---|---|---|
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Chief Tech/Sci/R&D Officer | 01/09/2016 |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Chief Tech/Sci/R&D Officer | 01/01/2012 |
CARISMA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Princess Margaret Hospital Foundation | Corporate Officer/Principal | - |
The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
Formación de Glen C. MacDonald.
University of Guelph | Undergraduate Degree |
University of Manitoba | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Health Technology |
Leucadia Finance Partners, Inc.
Leucadia Finance Partners, Inc. Financial ConglomeratesFinance Leucadia Finance Partners, Inc. provides investment services. The company was founded on January 12, 2014 and is headquartered in Vancouver, Canada. | Finance |
Princess Margaret Hospital Foundation | |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Viventia Bio, Inc.
Viventia Bio, Inc. BiotechnologyHealth Technology Viventia Bio, Inc. operates as a biologics oncology company, which focuses on designing, engineering, and developing targeted protein therapeutics. The company was founded by Leslie Lewis Dan in October 2012 and is headquartered in Winnipeg, Canada. | Health Technology |